Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Over 90% of human pathogenic viruses ... has developed a clinical-ready pan-herpesvirus drug candidate, NV-HHV-1 that has ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...

Integrated analyses of the Phase 2 PAISLEY-SLE and PAISLEY LTE studies showed that Sotyktu maintained a consistent safety profile and durable efficacy in patients with moderate-to-severe SLE with up ...

The study demonstrated a substantial clinical burden from multiple viral infections in recipients of allogeneic hematopoietic cell transplants — especially among patients with cytomegalovirus (CMV) ...

Overall, tailoring an HIV treatment regimen to individuals’ clinical and social context can help mitigate the persistent barriers to care access. Switching treatment is not just a clinical decision ...

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...

An investigation was continuing Wednesday after human remains were discovered at a construction site in Palm Beach County, according to the sheriff's office. The Palm Beach County Sheriff's Office ...

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from the destruction of insulin-producing β-cells in the ...